Folks, The above is a link to full text of an article in the November 20, 2003 issue of the New England Journal of Medicine. If this is a duplicate posting (PTResearcher posts this sort of thing!), I apologize. It is one of the better summaries I have seen. Of note: --> For Keribug: this includes info about levels <100 ug/dl indicating prolactinoma -- of micro or macro size. Finally, somebody got it right! Now, if only docs would read this material!! --> For everyone who is trying to conceive: good information about which med is preferred if you're trying for pregnancy; how much and for how long to use it. Includes rationale for this info -- I'm filing this one away for future reference. For my sake, it's bad news because Parlodel made me sick, but so would pregnancy, so what the heck! I was initially thrown off by the intro, expecting a case-study piece rather than a more comprehensive presentation about prolatctinoma in genera. I've seen the intro before and passed on reading the article for this reason. All this is simply to say that if at first it seems off-target, keep reading. There is some very good and basic info here -- this is a good one to pass along to all of our respective docs. ![]() | 